LCMV gp33-41 TFA
|
L659163-1mg
|
≥99% |
N/A |
1mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
LCMV gp33-41 TFA
|
L659163-10mg
|
≥99% |
N/A |
10mg
|
¥ 2900.9
|
期货,请咨询 |
阿拉丁 |
L-Moses dihydrochloride
|
L659136-5mg
|
|
N/A |
5mg
|
¥ 5200.9
|
期货,请咨询 |
阿拉丁 |
L-Moses dihydrochloride
|
L659136-10mg
|
|
N/A |
10mg
|
¥ 8400.9
|
期货,请咨询 |
阿拉丁 |
L-365260 hemihydrate
|
L659047-5mg
|
≥99% |
N/A |
5mg
|
¥ 1860.9
|
期货,请咨询 |
阿拉丁 |
LCKLSL hydrochloride
|
L658992-5mg
|
≥99% |
N/A |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
LCKLSL hydrochloride
|
L658992-25mg
|
≥99% |
N/A |
25mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
LCKLSL hydrochloride
|
L658992-10mg
|
≥99% |
N/A |
10mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
LEESGGGLVQPGGSMK acetate
|
L658981-5mg
|
≥98% |
2096980-79-7 |
5mg
|
¥ 3319.9
|
现货 |
阿拉丁 |
LEESGGGLVQPGGSMK acetate
|
L658981-10mg
|
≥98% |
2096980-79-7 |
10mg
|
¥ 5799.9
|
现货 |
阿拉丁 |
L-Hyoscyamine-d3
|
L658955-1mg
|
≥98% |
N/A |
1mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
Lesogaberan hydrochloride
|
L658928-5mg
|
≥98% |
N/A |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Lesogaberan hydrochloride
|
L658928-25mg
|
≥98% |
N/A |
25mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
Lesogaberan hydrochloride
|
L658928-10mg
|
≥98% |
N/A |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
LXW7 TFA
|
L658923-5mg
|
≥98% |
N/A |
5mg
|
¥ 28000.9
|
期货,请咨询 |
阿拉丁 |
LXW7 TFA
|
L658923-1mg
|
≥98% |
N/A |
1mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
LXW7 TFA
|
L658923-10mg
|
≥98% |
N/A |
10mg
|
¥ 38000.9
|
期货,请咨询 |
阿拉丁 |
Lafadofensine (D-(-)-Mandelic acid)
|
L658906-5mg
|
≥99% |
N/A |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Lafadofensine (D-(-)-Mandelic acid)
|
L658906-25mg
|
≥99% |
N/A |
25mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
Lafadofensine (D-(-)-Mandelic acid)
|
L658906-10mg
|
≥99% |
N/A |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
Lenvatinib-d4
|
L658901-1mg
|
≥99% |
N/A |
1mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
L-Buthionine-(S,R)-sulfoximine hydrochloride
|
L658869-50mg
|
|
N/A |
50mg
|
¥ 600.9
|
期货,请咨询 |
阿拉丁 |
Lenalidomide-C4-NH2 hydrochloride
|
L658859-500mg
|
≥98% |
N/A |
500mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
Lenalidomide-C4-NH2 hydrochloride
|
L658859-100mg
|
≥98% |
N/A |
100mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |